Oncology News | pharmaphorum

News

AZ/Daiichi Sankyo's partnership makes progress in lung cance...

AstraZeneca and Daiichi Sankyo have announced data from two drugs in lung cancer, which they are developing as part of their ongoing partnership.

News

DNA strand and Cancer Cell Oncology Research Concept 3D rendering

RedX Pharma CEO focuses on pipeline that found Lilly's risin...

Back in 2017, the UK biotech RedX Pharma had to sell its prized asset after administrators stepped in to stave off a debt crisis, with Loxo Oncology snapping up the BTK inhibitor for $40 mi

News

Doctors warn pandemic has pushed lung cancer services back 2...

Governments must act to restore the damage done to lung cancer services during the pandemic in order to reduce further avoidable deaths, according to a report drawn up as part of this week'

News

Merck, Pfizer get EU nod for Bavencio as bladder cancer main...

Pfizer and partner Merck KGaA now have approval on both sides of the Atlantic for their checkpoint inhibitor Bavencio as a first-line maintenance therapy for bladder cancer, stealing a marc

News

AZ says Calquence is a safer drug than Imbruvica

AstraZeneca’s fast-growing BTK inhibitor Calquence is already challenging class leader Imbruvica from Johnson & Johnson/AbbVie in the treatment of chronic lymphocytic leukaemia (CLL).

News

GSK/Merck's hopeful bintrafusp alfa fails in key lung cancer...

GlaxoSmithKline’s big gamble on a cancer drug developed by Germany’s Merck KGaA looks unlikely to pay out, after bintrafusp alfa failed to outperform US-based Merck & Co’s Keytruda in a

AZ/Daiichi Sankyo's partnership makes progress in lung cance...

RedX Pharma CEO focuses on pipeline that found Lilly's risin...

Doctors warn pandemic has pushed lung cancer services back 2...

Merck, Pfizer get EU nod for Bavencio as bladder cancer main...

AZ says Calquence is a safer drug than Imbruvica

GSK/Merck's hopeful bintrafusp alfa fails in key lung cancer...

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

News

Editor's Picks